Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Fibronectin Antikörper (AA 313-607)

Der Kaninchen Polyklonal Anti-Fibronectin-Antikörper wurde für WB, IHC, IP, FACS und ICC validiert. Er ist geeignet, Fibronectin in Proben von Human zu detektieren. Es sind 3+ Publikationen verfügbar.
Produktnummer ABIN1077665

Kurzübersicht für Fibronectin Antikörper (AA 313-607) (ABIN1077665)

Target

Alle Fibronectin Antikörper anzeigen
Fibronectin

Reaktivität

  • 147
  • 60
  • 58
  • 28
  • 18
  • 12
  • 6
  • 3
  • 3
  • 2
  • 2
  • 1
Human

Wirt

  • 99
  • 88
  • 5
  • 2
Kaninchen

Klonalität

  • 109
  • 83
  • 1
Polyklonal

Konjugat

  • 82
  • 26
  • 12
  • 7
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Fibronectin Antikörper ist unkonjugiert

Applikation

  • 106
  • 72
  • 46
  • 45
  • 36
  • 26
  • 23
  • 22
  • 19
  • 19
  • 17
  • 13
  • 12
  • 10
  • 7
  • 7
  • 5
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Flow Cytometry (FACS), Immunocytochemistry (ICC)
  • Bindungsspezifität

    • 15
    • 15
    • 10
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 313-607

    Verwendungszweck

    Polyclonal Antibody to Fibronectin (FN)

    Spezifität

    The antibody is a rabbit polyclonal antibody raised against FN. It has been selected for its ability to recognize FN in immunohistochemical staining and western blotting.

    Kreuzreaktivität

    Schwein

    Aufreinigung

    Antigen-specific affinity chromatography followed by Protein A affinity chromatography

    Immunogen

    Recombinant Fibronectin (FN)

    Isotyp

    IgG
  • Applikationshinweise

    Western blotting: 0.01-2 μg/mL,Immunohistochemistry: 5-20 μg/mL,Immunocytochemistry: 5-20 μg/mL,Flow cytometry:20 μg/mL,Optimal working dilutions must be determined by end user.,

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.32 mg/mL

    Buffer

    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

    Haltbarkeit

    24 months
  • Lu, Chen, Liu, Si, Zhao, Lai, Kang, Sun, Guo: "Molecular hydrogen regulates PTEN-AKT-mTOR signaling via ROS to alleviate peritoneal dialysis-related peritoneal fibrosis." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 34, Issue 3, pp. 4134-4146, (2021) (PubMed).

    Nishad, Mukhi, Tahaseen, Mungamuri, Pasupulati: "Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy." in: The Journal of biological chemistry, Vol. 294, Issue 44, pp. 16109-16122, (2020) (PubMed).

    Zheng, Hu, Huang, Xu, Yang, Li: "In vivo bioengineered ovarian tumors based on collagen, matrigel, alginate and agarose hydrogels: a comparative study." in: Biomedical materials (Bristol, England), Vol. 10, Issue 1, pp. 015016, (2015) (PubMed).

  • Target

    Fibronectin

    Hintergrund

    FN1, CIG, FINC, LETS, MSF, GFND2, Anastellin, Migration-Stimulating Factor, Cold-Insoluble Globulin, Large, External, Transformation-Sensitive Protein
Sie sind hier:
Chat with us!